SUBSCRIBE
SUBSCRIBE

Morphic Therapeutic

NEWS
Business
AbbVie Invests $100 Million in Morphic Therapeutics to Develop Integrin Inhibitors for Fibrotic Diseases
Weeks after Waltham, Mass.-based Morphic Therapeutic secured $80 million in Series B financing that was supported in part by AbbVie Ventures, the company struck a deal with the pharma giant to collaborate on the development of therapies for fibrosis-related indications.
October 18, 2018
 · 
2 min read
 · 
Alex Keown
Business
$80 Million Series B Financing Funds Morphic Therapeutic’s Next-Generation Oral Integrin
Biotechnology company Morphic Therapeutic has just publicized their completion of a successful $80 million Series B financing meant to support their two lead programs in developing modern oral integrin therapies, as well as further other clinic programs.
September 25, 2018
 · 
3 min read
 · 
Elizabeth Glasure
Business
The Next Generation: Top 20 Life Science Startups to Watch in 2017
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.
January 3, 2017
 · 
11 min read
 · 
Mark Terry
What You Need to Know About Morphic Therapeutic
Business
What You Need to Know About Morphic Therapeutic
January 3, 2017
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
With Investments from Pfizer and AbbVie, Morphic Therapeutic Closes a $51.5 Million Series A Round
June 30, 2016
 · 
3 min read
Load More
AWARDS
  • NextGen Class of 2017
JOBS
IN THE PRESS
Drug Development
Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Set
October 9, 2023
 · 
1 min read
Genetown
Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of Absence
September 26, 2023
 · 
3 min read
Drug Development
Morphic to Present Positive EMERALD-1 Phase 2a Data for MORF-057 in Patients with Moderate to Severe Ulcerative Colitis in Abstract for UEGW 2023
September 22, 2023
 · 
8 min read
Genetown
Morphic Announces Participation in 2023 Wells Fargo Healthcare Conference
August 29, 2023
 · 
1 min read
Genetown
Morphic to Present at the Canaccord Genuity 43rd Annual Growth Conference
August 9, 2023
 · 
1 min read
Business
Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2023
August 3, 2023
 · 
11 min read
Genetown
Morphic to Present at the 2023 Jefferies Global Healthcare Conference
June 6, 2023
 · 
1 min read
Genetown
Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference
May 12, 2023
 · 
1 min read
Genetown
Morphic Presents New Biomarker Data at DDW 2023 Supporting MORF-057 Program in Ulcerative Colitis
May 11, 2023
 · 
4 min read
Genetown
Morphic Therapeutic Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 5, 2023
 · 
2 min read
Load More